Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement

Part of paid clinical trials in New York, New York.

Sponsor
Efforia, Inc
Study ID
NCT07442864
Status
Recruiting

Conditions

  • Hunger
  • Weight Change

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Leptin Balance Formula — DIETARY_SUPPLEMENT
    Participants will self-administer the Leptin Balance Formula daily for 12 weeks according to product labeling. The supplement is commercially available and includes African mango seed extract, chromium picolinate, Ceylon cinnamon, and alpha lipoic acid.

Study Details

This study evaluates changes in hunger perception and body composition-related measures following daily use of a commercially available dietary supplement formulated to support leptin-related metabolic signaling. Adult participants will self-administer the supplement for 12 weeks and complete periodic self-reported assessments related to appetite, hunger, and weight-related outcomes. Participants serve as their own control, with comparisons made between baseline and follow-up measurements. The study is designed to generate preliminary, real-world evidence regarding supplement use in a general wellness context.

Key Dates

Start date
Sep 10, 2025
Status verified
Sep 2025
Primary completion
Sep 10, 2026
Completion
Sep 10, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Single Arm longitudinal where participants act as their own control
    Single Arm longitudinal where participants act as their own control

Primary Outcome Measure

Change in Hunger Perception [ Time Frame: Baseline and Week 12 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
EfforiaNew YorkNew York10003
Matthew Amsden
(646) 679-2479

Find similar trials in New York, NY

By research site

Related Studies